Bhavan Biotec India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.10 Cr
- Revenue Growth -82.00%
- Profit Growth 6.36%
- Ebitda 51.64%
- Net Worth 3.04%
- Total Assets -17.91%
About Bhavan Biotec India
Bhavan Biotec India Private Limited (BBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 January 2018 (Seven years and one month 1 days old ). Its registered office is in Dharmapuri, Tamil Nadu, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.10 Cr.
Ravi Aruljothi and Theerthagiri Ravi serve as directors at the Company.
Company Details
- Location
Dharmapuri, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999TN2018PTC120624
- Company No.
120624
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2018
- Date of AGM
05 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Bhavan Biotec India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Theerthagiri Ravi  | Managing Director | 22-Jan-2018 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravi Aruljothi | Director | 22-Jan-2018 | Current |
Financial Performance of Bhavan Biotec India.
Bhavan Biotec India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 82% decrease. The company also saw a slight improvement in profitability, with a 6.36% increase in profit. The company's net worth moved up by a moderate rise of 3.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhavan Biotec India?
Unlock access to Bhavan Biotec India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹11.00 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 1.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2024 | Canara Bank | ₹1.10 Cr | Open |
How Many Employees Work at Bhavan Biotec India?
Unlock and access historical data on people associated with Bhavan Biotec India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhavan Biotec India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhavan Biotec India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.